kabutan

K Pharma, First Half Net Income Loss Widens, Apr-Jun Net Income Loss Widens

Thu Aug 14, 2025 8:00 am JST Earnings

4896 K Pharma,Inc. 【J-GAAP】

Earnings Report

K Pharma,Inc. <4896> [TSE Growth] announced its financial results in the morning on August 14th (08:00). The net loss (non-consolidated) for the cumulative second quarter of the fiscal year ending December 2025 (January to June) expanded to a loss of 444 million yen (compared to a loss of 426 million yen in the same period last year).

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the net loss for the July to December period (second half) is expected to expand to a loss of 692 million yen (compared to a loss of 420 million yen in the same period last year).

In the most recent three-month period, from April to June (2Q), the net loss expanded to loss of 245 million yen (compared to a loss of 193 million yen in the same period last year).

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Jun, 2024 0 -423 -422 -426 -36.8 ー Aug 14, 2024 J-GAAP
Jan - Jun, 2025 0 -437 -437 -444 -38.3 ー Aug 14, 2025 J-GAAP
YoY － -3.3% -3.6% -4.2% -4.3%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 Guidance ー -436 -436 -443 -38.2 0 Jul 14, 2025 J-GAAP
Jan - Jun, 2025 Results 0 -437 -437 -444 -38.3 0 Aug 14, 2025 J-GAAP
Revision Rate － -0.2% -0.2% -0.2% -0.4%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 0 -413 -414 -420 -36.2 0 Feb 13, 2025 J-GAAP
Jul - Dec, 2025 Guidance ー -686 -685 -692 -59.6 0 Aug 14, 2025 J-GAAP
YoY － -66.1% -65.5% -64.8% -64.7%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 1,000 366 344 260 25.4 0 Feb 14, 2024 J-GAAP
Dec, 2024 0 -836 -836 -846 -72.9 0 Feb 13, 2025 J-GAAP
Dec, 2025 Guidance ー -1,123 -1,122 -1,136 -97.9 0 Jul 14, 2025 J-GAAP
YoY － -34.3% -34.2% -34.3% -34.2%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 0 -193 -192 -193 -16.7 -Inf Aug 14, 2024 J-GAAP
Jul - Sep, 2024 0 -197 -197 -198 -17.1 -Inf Nov 14, 2024 J-GAAP
Oct - Dec, 2024 0 -216 -217 -222 -19.1 -Inf Feb 13, 2025 J-GAAP
Jan - Mar, 2025 0 -198 -198 -199 -17.2 -Inf May 15, 2025 J-GAAP
Apr - Jun, 2025 0 -239 -239 -245 -21.2 -Inf Aug 14, 2025 J-GAAP
YoY － -23.8% -24.5% -26.9% -27.0%

Related Articles